This SBIR Phase I contract from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at $355,000 and awarded to Adelphi Technology Inc. to develop a compact neutron source for neutron capture therapy to treat pontine glioma, a rare form of pediatric brain cancer. The solicitation sought innovative early-stage concepts for new pediatric and rare cancer therapies, diagnostics or preventative strategies through the NCI Small Business Innovation Research Concept Award Program. This total small business set-aside award will support enhancing the contractor's entrepreneurial skills and commercialization plans over the one-year period of performance ending January 2023. The work is to be conducted at the prime contractor's facility in Redwood City, California.
Generated 12/29/23, 4:45 PM